OFF-LABEL USE OF SECOND-GENERATION ANTIPSYCHOTICS

被引：0
|
作者：
Spina, Edoardo [1 ,2 ]
Fava, Giuseppina [1 ]
Makos, Xenofon [1 ]
机构：
[1] Univ Messina, Dept Clin & Expt Med & Pharmacol, Pharmacol Sect, Policlinico Univ,Via Consolare, I-98125 Messina, Italy
[2] IRCCS, Ctr Neurolesi BoninoPulejo, Messina, Italy
来源：
CLINICAL NEUROPSYCHIATRY | 2009年 / 6卷 / 01期
关键词：
Antipsychotics; Off label; Bipolar depression; Behavioral and psychological symptoms of dementia; Obsessive-compulsive disorder; Borderline personality disorder; Dopaminergic psychosis; Generalized anxiety disorder;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
All second-generation antipsychotics are licensed for the treatment of schizophrenia. Some of these agents are also approved for the treatment of acute mania and for maintenance therapy of bipolar disorder. In view of a broader spectrum of activity and a more favourable tolerability profile as compared to first-generation compounds, second generation antipsychotics are increasingly used oil-label for the treatment of many psychiatric conditions, either as monotherapy, or as an augmentation strategy. This article reviews the available data concerning the use of second generation antipsychotics in the most common off-label indications in adult and elderly psychiatric patients, such as bipolar depression, behavioural and psychological symptoms of dementia, obsessive-compulsive disorder, borderline personality disorder, dopaminergic psychosis and generalized anxiety disorder.
引用
收藏
页码：11 / 20
页数：10
相关论文
共 50 条
  • [1] Off-Label Use of Second-generation Antipsychotics in Bipolar Disorder: A Survey of Italian Psychiatrists
    Salvi, Virginio
    Cerveri, Giancarlo
    Aguglia, Andrea
    Calo, Salvatore
    Corbo, Mariangela
    Martinotti, Giovanni
    Serafini, Gianluca
    Signorelli, Maria Salvina
    Aguglia, Eugenio
    Amore, Mario
    Biggio, Giovanni
    Di Sciascio, Guido
    Mencacci, Claudio
    JOURNAL OF PSYCHIATRIC PRACTICE, 2019, 25 (04) : 318 - 327
  • [2] Use of Administrative Data to Identify Off-Label Use of Second-Generation Antipsychotics in a Medicaid Population
    Hartung, Daniel M.
    Middleton, Luke
    McFarland, Bentson H.
    Haxby, Dean G.
    McDonagh, Marian S.
    McConnell, K. John
    PSYCHIATRIC SERVICES, 2013, 64 (12) : 1236 - 1242
  • [3] Trends in Off-Label Use of Second-Generation Antipsychotics in the Medicare Population From 2006 to 2012
    Driessen, Julia
    Baik, Seo Hyon
    Zhang, Yuting
    PSYCHIATRIC SERVICES, 2016, 67 (08) : 898 - 903
  • [4] OFF-LABEL USE OF SECOND-GENERATION ANTIPSYCHOTICS IN BORDERLINE PERSONALITY DISORDER: A SURVEY OF ITALIAN PSYCHIATRISTS
    Aguglia, Andrea
    Serafini, Gianluca
    Nebbia, Jacopo
    Salvi, Virginio
    Martinotti, Giovanni
    Corbo, Mariangela
    Signorelli, Maria Salvina
    Mineo, Ludovico
    Mencacci, Claudio
    Di Sciascio, Guido
    Biggio, Giovanni
    Aguglia, Eugenio
    Amore, Mario
    JOURNAL OF PERSONALITY DISORDERS, 2021, 35 (03) : 321 - 335
  • [5] Off-label use of second generation antipsychotics in all Austrian inpatient population
    Konstantinidis, A.
    Moser, U.
    Darau, C.
    Grohmann, R.
    Engel, R.
    Kasper, S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 141 - 141
  • [6] Validity of Administrative Data To Identify Off-Label Use of Second Generation Antipsychotics
    Hartung, Daniel M.
    Middleton, Luke
    McFarland, Bentson H.
    McDonagh, Marian S.
    Haxby, Dean G.
    McConnell, K. J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 167 - 167
  • [7] Off-label use of antipsychotics: Rethinking "off-label"
    Groleger, Urban
    PSYCHIATRIA DANUBINA, 2007, 19 (04) : 350 - 353
  • [8] Off-Label Prescribing of Second-Generation Antipsychotics to Elderly Veterans with Posttraumatic Stress Disorder and Dementia
    Semla, Todd P.
    Lee, Austin
    Gurrera, Ronald
    Bajor, Laura
    Li, Mingfei
    Miller, Donald R.
    Smith, Eric G.
    Wang, Chao
    Wan, Yun
    Kazis, Lewis E.
    Bauer, Mark S.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 (08) : 1789 - 1795
  • [9] Factors Associated With Off-Label Utilization of Second-Generation Antipsychotics Among Publicly Insured Adults
    Horvitz-Lennon, Marcela
    Volya, Rita
    Hollands, Simon
    Zelevinsky, Katya
    Mulcahy, Andrew
    Donohue, Julie M.
    Normand, Sharon-Lise T.
    PSYCHIATRIC SERVICES, 2021, 72 (09) : 1031 - 1039
  • [10] Off-label use of second-generation antipsychotics among adult patients with bipolar disorder in a large managed care population
    Demland, J. A.
    Jing, Y.
    Kelton, C. M.
    Guo, J. J.
    Wigle, P. R.
    VALUE IN HEALTH, 2008, 11 (03) : A131 - A131
12345